MedTrace Logo

Female Muscle Enhancement

NCT05397418 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2024-06-11

No results posted yet for this study

Summary

Participating in regular physical activity has been shown to reduce the risk of developing some diseases and disabilities that can occur with ageing. Muscles naturally decline with age, and in females this appears to occur more so around the time of menopause. Time, work, family commitments and the availability of facilities have all been identified as barriers to exercise in middle age.

Increasing activity levels in middle age appears to improve muscle function and bone health. However, there is a lack of evidence in how muscle function responds to low impact resistance exercise in middle aged females.

This study aims to assess the effectiveness and the mechanisms associated with building muscle as well as the effect on quality of life in middle aged (40-60 years) females using a low impact resistance training programme.

Conditions

  • Muscle Function

Interventions

BEHAVIORAL

Supervised resistance exercise program

12 week supervised low impact resistance training program

BEHAVIORAL

Unsupervised resistance exercise program

12 week unsupervised low impact resistance training program

Sponsors & Collaborators

  • P.volve LLC

    collaborator UNKNOWN

  • University of Exeter

    lead OTHER

Principal Investigators

  • Francis Stephens · University of Exeter

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-01
Primary Completion
2023-11-23
Completion
2023-11-23

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05397418 on ClinicalTrials.gov